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 CS are observed in patients above 35 years with a male predilection.
 CS require complete excision, adequate surgical margin to enable diagnostic evaluation and prevent recurrence.a r t i c l e i n f o
Article history:
Received 6 August 2015
Received in revised form
27 September 2015





Upper lip* Corresponding author.
E-mail addresses: sandra.girgis@nhs.net (S. Girgis),
uk (G. Gillan), kim.piper@bartshealth.nhs.uk (K. Piper
http://dx.doi.org/10.1016/j.amsu.2015.10.001
2049-0801/© 2015 The Authors. Published by Elsevie
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Background: Chondroid syringomas (CS) are rare benign mixed tumours. Clinical differentiation can be
misleading due to the silent presentation, with only histopathological ﬁndings conﬁrming the diagnosis.
Case report: A 23-year-old Caucasian gentleman presented with an eighteen month history of increasing
size of his exophytic upper lip mass.
The initial clinical impression was thought to be related to the skin. Following a punch biopsy, histo-
pathology conﬁrmed appearance in keeping with part of a chondroid syringoma with subsequent
excision of the lesion.
Discussion: CS present as a slow-growing, asymptomatic, non-tender, nonulcerated, smooth, ﬁrm sub-
cutaneous, or intradermal nodule and can range from 0.5 to 3.0 cm, predominantly occurring in the head
and neck region in patients aged above 35 years with a male predication. The most effective diagnostic
method is microscopic examination. The gold standard treatment modality is by complete excision with
a margin of normal tissue in order to examine the histopathologic features and prevent recurrence.
Conclusion: CS should be included as a differential diagnosis of facial subcutaneous skin lesions in middle
aged male patients. Careful evaluation, with a view of total excision and adequate surgical margin will
enable diagnostic conﬁrmation, whilst maintaining the aesthetic and functional unit.
© 2015 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Limited. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Chondroid syringomas (CS) are rare benign mixed tumours that
exhibit both epithelial and mesenchymal components, originating
from the sweat glands [1]. Occurrence rates have been reported to
be 0.01%e0.098% of all primary skin tumours [2], typically occur-
ring in the head and neck region [2,3] between the ages of 20e60
years with a male predominance [4].
CS of the upper lip is a rare clinical entity, and to our knowledge
there has have only been four reported cases in the Englishgerrad.gillan@homerton.nhs.
).
r Ltd on behalf of IJS Publishing Grliterature to date [5e8].
Clinical differentiation can bemisleading and difﬁcult due to the
silent presentation, with only histopathological ﬁndings conﬁrm-
ing the diagnosis. Complete excision is necessary in such cases.2. Case report
A 23 year old gentleman presented with an eighteen month
history of increasing size of his exophytic upper lip mass. A 23-year
old Caucasian gentlemanwas referred by his general practitioner to
our oral and maxillofacial (OMF) unit regarding an exophytic
polypoid mass on his right upper lip. The lesion was asymptomatic
and had been slowly increasing in size over an eighteen month
period, Fig. 1.oup Limited. This is an open access article under the CC BY-NC-ND license (http://
Fig. 2. Excised lesion.
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causes and also address the aesthetic appearance. He denied any
family history of similar lesions and this was the only solitary
episode relating to the swelling. He was medically ﬁt and well with
no known allergies. He did not smoke and alcohol consumption
was minimal.
On clinical examination, he presented with an oval, well cir-
cumscribed 15 mm diameter spheroidal swelling of his right upper
lip. The lesionwas ﬁxed to the skin, smooth with a reddish hue. The
lesion was in close proximity to his vermilion border. Following a
punch biopsy, histopathology conﬁrmed an appearance which was
in keeping with a diagnosis of chondroid syringoma. The mass was
subsequently excised
2.1. Investigations
At the time of presentation it was thought to be related to the
skin and although at that stage, the nature of the lesion was un-
certain, but working differential diagnosis of sebaceous cyst and
dermoid cyst wasmade. A punch biopsywas carried out under local
anaesthetic, 2 ml Lignospan (2% lidocaine and 1: 80 0000 epineph-
rine), to exclude any sinister pathology and conﬁrm diagnosis.
Histological ﬁnding demonstrated myxochondroid areas
together with duct-like structures, suggestive of chondroid
syringoma.
2.2. Treatment
Following discussions with the patient regarding the total
excision, he wished to have the procedure carried out under gen-
eral anaesthetic due to his nervous predisposition and anxiety of
having the procedure carried out under local anaesthetic.
The lesion was then excised with a margin of healthy tissue
which extended beyond the vermilion border of his upper right lip,
Fig. 2.
Assessing the defect, a local ﬂap reconstruction would have
resulted in signiﬁcant collateral scarring and deformity in a
prominent facial region. The decision was then taken to allow
healing via secondary intention. Topical chloramphenicol was
applied to the wound bed, along with Jelonet and a Hydrocell non-
adhesive foam dressing sutured in place for a week, to avoid
opportunistic infections. Fig. 3.
The excised specimenwas sent for histopathology, subsequently
conﬁrming an appearance in keeping with the diagnosis of chon-
droid syringoma, Fig. 4.Fig. 1. The lesion at presentation.2.3. Follow-up
The gentleman had an uneventful recovery with a satisfactory
cosmetic and functional outcome, and did not require any further
ﬂap reconstruction, Figs. 5 and 6).3. Discussion
CS present as slow-growing, asymptomatic, non-tender, non-
ulcerated, smooth, ﬁrm subcutaneous, or intradermal nodules and
can range from 0.5 to 3.0 cm [9e11], andmay also exhibit a purplish
or reddish hue [1,10]. The lesion is commonly mobile and distinct
from the surrounding tissues [11,12]. However Sunguar et al. re-
ported a benign case where rapid growth, ulceration and necrosis
was evident at the tumour site [10]. They predominantly occur in
the head and neck region with varying rates; 66% [3] e 80% [13] of
cases. In descending order of frequency, the areas affected involve
the nose, cheek, upper lip, scalp, forehead, and chin [1,3]. Other
reported sites include the chest, abdomen, scrotum, penis, foot,
eyelid, orbit, vulva, axilla and brain [1,9,11].
CS have been observed in patients aged above 35 [3,13,14], with
a male predilection and a male-to-female ration of 2:1 [3,14].
Historically, Billroth in 1859 ﬁrst identiﬁed these lesions asFig. 3. Topical chloramphenicol applied to the wound bed, along with Jelonet and a
Hydrocell non-adhesive foam dressing sutured in place for a week, to avoid opportu-
nistic infections.
Fig. 4. Haematoxylin & eosin stain (x10) demonstrating myxochondroid areas
together with duct-like structures in keeping with chondroid syringoma.
Fig. 6. Healed area 9 months post-op.
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logically properties of the mixed tumours of the salivary glands
[11]. In 1961, they were subsequently given the term by Hirsch and
Helwig who proposed that theymay originate either from apocrine
or eccrine sweat glands [9]. CS may evolve from entrapped ectopic
cell rest of embryologic origin stimulated to proliferate by an un-
known factor [1].
Due to the rare and unremarkable clinical presentation, CS can
be overlooked andmisdiagnosed as skin lesions such as dermoid or
sebaceous cysts, neuroﬁbromas, dermatoﬁbromas, basal cell car-
cinomas, squamous cell carcinomas, histicoytomas, pilomatrix-
omas, and seborrheic keratosis [1,9,14].
CS can also be preceded by trauma, in areas such as the sole of
the foot where ulceration may occur [11].
The most effective diagnosis is conﬁrmed by microscopic ex-
amination [15], requiring the total excision of the lesion.
Although CS are usually benign, malignant variants have been
reported.
It is therefore important to obtain an incisional biopsy if in
doubt to ensure appropriate management. Malignant chondroid
syringomas (MCS) may arise de novo or from an incompletely
excised benign CS that has recurred and undergone malignant
transformation [12,16]. It is of note that no cases of malignant
degeneration or transformation of benign tumour have beenFig. 5. One week post-op.reported [1].
Microscopic ﬁndings are more aggressive and include nuclear
pleomorphism, cytologic atypia, increased mitotic ﬁgures, inﬁltra-
tive margin, satellite tumour nodules, and tumour necrosis [1,9].
Wide excisionwith a broadmargin is themost reliable treatment to
date [16].
Though adjuvant radiotherapy is often unsuccessful, skeletal
metastasis have been shown to respond. Combination chemo-
therapy in patients with metastases is not reported to be beneﬁcial
[16].4. Conclusion
CS of the upper lip are rare benign clinical entities, predomi-
nately occurring in middle aged male patients. Careful clinical and
histological evaluation is required to obtain diagnosis, with a view
of total excision and an adequate surgical margin to prevent
recurrence. Healing via secondary intention could be considered to
avoid unsightly scars from local ﬂap reconstructions, and maintain
the aesthetic and functional unit for a satisfactory patient outcome.Ethical approval
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